Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8501423
Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
granted -
US 8501194
Vaccine for viruses that cause persistent or latent infections
granted -
US 8501229
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
granted -
US 8501191
FGFR2-IIIb fusion proteins and methods of making them
granted -
US 8501188
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
granted -
US 8501184
High affinity human antibodies to PCSK9
granted -
US 8501247
Pest control using natural pest control agent blends
granted -
US 8501920
Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats
granted -
US 8501926
Malaria vaccine
granted -
US 8501953
PKM2 modulators for use in the treatment of cancer
granted -
US 8501964
Serotonin reuptake inhibitors
granted -
US 8501803
Garcinia derivative, its preparing method and medicinal use
granted -
US 8501899
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 8501912
Filipil compositions and methods for treating cancer
granted -
US 8501905
Synthetic cell platforms and methods of use thereof
granted -
US 8501783
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
granted -
US 8501750
Heterocyclic compound and use thereof
granted -
US 8501766
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
granted -
US 8501746
Organic compounds
granted -
US 8501740
Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors
granted -
US 8501727
Short acting benzothiazepine calcium channel blockers and uses thereof
granted -
US 8501713
Drug combinations for the treatment of duchenne muscular dystrophy
granted -
US 8501930
Peptide-based in vivo siRNA delivery system
granted -
US 8501943
Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.